In smooth muscle cells and cardiomyocytes, NRP1 down-regulation reduces TGF-β canonical pathway, with loss of NRP1 expression in these cell types decreasing mouse survival and correlating with cardiomyopathy [38]. The gene discussed is NRP1; the disease is cardiomyopathy.